Bio-Rad Laboratories (NYSE:BIO.B) Hits New 52-Week High – Time to Buy?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s stock price reached a new 52-week high during trading on Thursday . The company traded as high as $359.22 and last traded at $357.65, with a volume of 326 shares. The stock had previously closed at $357.05.

Bio-Rad Laboratories Stock Up 0.2 %

The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.52 and a current ratio of 6.14. The firm has a market capitalization of $10.01 billion, a P/E ratio of -13.09 and a beta of 0.72. The stock has a 50 day moving average of $336.01 and a 200-day moving average of $328.84.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its earnings results on Wednesday, October 30th. The company reported $2.01 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%. The business had revenue of $649.73 million for the quarter.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.